Platform-14 | Coronary Drug Eluting Balloon | Which Medical Device
Categorised under:
Cardio-thoracic
>
Coronary intervention
>
Drug eluting balloons
From Platform-14
In the last 18 months Paclitaxel coating technology has advanced. Platform 14 use smaller drug crystals for a higher drug uptake and SV (sustained value) meaning the drug being active in the vessel wall for over a month. The comapany claims that no one has a more effective drug coating/transfer for PTCA. This stable coating has allowed platform 14 to make balloons as small as 1.5mm up to 14mm in diameter. There is a sealing layer that protects the drug from wash off effect.
Many Years Experience
Your opinion matters to others - rate this device or add a comment
There are no currently similar devices - Click here to suggest a device
Did you know you can Register for FREE with this website?
Registration gives you full access to all of the features of WhichMedicalDevice. Find out more ...
WhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.